Overview:
Semax is a synthetic peptide derived from a fragment of adrenocorticotropic
hormone (ACTH 4–10) with modifications to enhance stability. It has been
studied primarily for neuroprotective and cognitive-related effects.
Proposed Mechanisms:
- Modulation of brain-derived neurotrophic factor (BDNF)
- Influence on dopaminergic and serotonergic neurotransmission
- Potential antioxidant and anti-inflammatory activity in neural tissue
- Regulation of gene expression associated with neuronal plasticity
Research Areas:
- Cognitive enhancement and attention
- Post-stroke recovery (studied primarily in Russia)
- Anxiety and stress response
- Neuroprotection under hypoxic conditions
Evidence Status:
Some clinical research exists, mainly from Eastern Europe, but large-scale
international trials are limited.
It is not approved by major Western regulatory
agencies.
FOR RESEARCH USE ONLY